Screener
Cogent Biosciences, Inc. COGT Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$96.41M-31.1% | -$97.35M-35.2% | -$102.49M-50.9% | -$80.93M-14.6% | -$73.53M-24.7% | ||
| $741K+13.1% | $626K-2.2% | $628K+0.5% | $641K+3.4% | $655K+8.1% | ||
| $17.11M+76.1% | $16.91M+68.9% | $15.75M+57.9% | $10.6M+2.4% | $9.72M-3.0% | ||
| -$77.27M-41.7% | -$86.88M-30.6% | -$79.11M-30.6% | -$64.29M-23.7% | -$54.54M-27.7% | ||
| $370K+182% | $449K-17.9% | $811K+981% | $65K-76.8% | $131K-11.5% | ||
| —— | -$36.46M-153% | -$322.77M-623% | -$155.05M-358% | $8.91M+111% | ||
| —— | —— | $12.32M— | $12.32M— | $12.32M— | ||
| —— | —— | $13.66M— | $13.66M— | $13.66M— | ||
| $2.96M-93.7% | $52.54M+110% | $588.67M+2,264,012% | $217.37M+34,734% | $47.23M— | ||
| -$60.04M-3,864% | -$70.8M-354% | $186.8M+16,578% | $0-100% | $1.6M— | ||
| -$77.64M-42.0% | -$87.33M-30.2% | -$79.92M-31.8% | -$64.35M-23.1% | -$54.67M-27.6% |
FAQ
- How much cash does Cogent Biosciences, Inc. generate?
- Cogent Biosciences, Inc. (COGT) generated -$307.5M in operating cash flow over the trailing twelve months.
- What is Cogent Biosciences, Inc.'s free cash flow?
- After $1.7M of capital expenditures, Cogent Biosciences, Inc.'s free cash flow was -$309.2M over the trailing twelve months, down 31.8% year over year.
- Where does Cogent Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.